What Researchers Did
Researchers reported a case of atypical calciphylaxis in a 63-year-old woman receiving warfarin, who was successfully treated with enoxaparin substitution and hyperbaric oxygen therapy.
What They Found
The patient's lower extremity ulcers resolved after 40 sessions of hyperbaric oxygen therapy and switching from warfarin to enoxaparin. This outcome is notable given that up to 80% of calciphylaxis patients typically die within one year of diagnosis.
What This Means for Canadian Patients
For Canadian patients presenting with atypical calciphylaxis while on warfarin, this case suggests that discontinuing warfarin and considering hyperbaric oxygen therapy may be a beneficial treatment strategy. Early recognition and a multidisciplinary approach could potentially improve outcomes in this rare and often fatal condition.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The primary limitation of this study is that it is a single case report, which limits the generalizability of its findings.